The global procalcitonin antibody market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of sepsis and other inflammatory diseases, which are major drivers for the procalcitonin antibody market. The increasing number of patients with sepsis and other inflammatory diseases will drive the demand for procalcitonin antibodies in hospitals and medical research institutions.
The global procalcitonin antibody market by type is segmented into polyclonal antibodies and monoclonal antibodies. Polyclonal antibodies are more commonly used than monoclonal antibodies due to their lower cost, higher availability, and ease of production process. However, monoclonal antibodies have an advantage over polyclonal antibodies as they can be produced in large quantities with high purity levels at a low cost per unit volume compared to polyclonal antibodies. Monoclonal antibody-based products are also preferred over polyclonal antibody-based products due to their ability to bind specifically with target proteins without cross-reactivity or interference from other proteins present in blood samples or serum samples that may interfere with detection results or cause false positives results when using immunoassays such as ELISA kits for detecting procalcitonin levels in blood samples or serum samples obtained from patients suffering from sepsis or other inflammatory diseases such as acute respiratory distress syndrome (ARDS).
North America accounted for the largest share of the global procalcitonin antibody market owing to its high adoption rate among hospitals and medical research institutions owing mainly due its advanced healthcare infrastructure coupled with favorable reimbursement policies by government authorities that encourage adoption among healthcare providers across North America region.
Some Of The Growth Factors Of This Market:
- Procalcitonin is a hormone that is released by the thyroid gland and the parathyroid glands in response to low calcium levels in the blood.
- The procalcitonin test can be used to diagnose bacterial infections, such as sepsis, pneumonia, and meningitis.
- The procalcitonin test can also be used to monitor patients with chronic kidney disease who are undergoing dialysis or have had a kidney transplant.
- Procalcitonin levels are elevated in patients with acute respiratory distress syndrome (ARDS).
- Procalcitonin levels are also elevated in patients with pancreatitis.
Industry Growth Insights published a new data on “Procalcitonin Antibody Market”. The research report is titled “Procalcitonin Antibody Market research by Types (Polyclonal Procalcitonin Antibody, Monoclonal Procalcitonin Antibody), By Applications (Hospital, Medical research institutions, Others), By Players/Companies Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo, Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Kitgen, Beijing KeyGen, Fantibody”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Procalcitonin Antibody Market Research Report
By Type
Polyclonal Procalcitonin Antibody, Monoclonal Procalcitonin Antibody
By Application
Hospital, Medical research institutions, Others
By Companies
Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo, Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Kitgen, Beijing KeyGen, Fantibody
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Procalcitonin Antibody Market Report Segments:
The global Procalcitonin Antibody market is segmented on the basis of:
Types
Polyclonal Procalcitonin Antibody, Monoclonal Procalcitonin Antibody
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Medical research institutions, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Roche Diagnostics
- bioMerieux
- HyTest
- Wondfo
- Ningbo Medicalsystem Biotechnology
- Snibe
- Vazyme Biotech
- Getein Biotech
- Hotgen Biotech
- Lumigenex
- Shanghai Medicine'nest Pharmaceutical
- Kitgen
- Beijing KeyGen
- Fantibody
Highlights of The Procalcitonin Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polyclonal Procalcitonin Antibody
- Monoclonal Procalcitonin Antibody
- By Application:
- Hospital
- Medical research institutions
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Procalcitonin Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Procalcitonin is a protein that is released by the body in response to infection or inflammation. Procalcitonin levels rise when there is an increased risk of serious medical complications, such as sepsis (a life-threatening condition caused by infection) or pneumonia (a lung infection).
Some of the key players operating in the procalcitonin antibody market are Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo, Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Kitgen, Beijing KeyGen, Fantibody.
The procalcitonin antibody market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Procalcitonin Antibody Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Procalcitonin Antibody Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Procalcitonin Antibody Market - Supply Chain
4.5. Global Procalcitonin Antibody Market Forecast
4.5.1. Procalcitonin Antibody Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Procalcitonin Antibody Market Size (000 Units) and Y-o-Y Growth
4.5.3. Procalcitonin Antibody Market Absolute $ Opportunity
5. Global Procalcitonin Antibody Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Procalcitonin Antibody Market Size and Volume Forecast by Type
5.3.1. Polyclonal Procalcitonin Antibody
5.3.2. Monoclonal Procalcitonin Antibody
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Procalcitonin Antibody Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Procalcitonin Antibody Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Medical research institutions
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Procalcitonin Antibody Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Procalcitonin Antibody Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Procalcitonin Antibody Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Procalcitonin Antibody Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Procalcitonin Antibody Demand Share Forecast, 2019-2026
9. North America Procalcitonin Antibody Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Procalcitonin Antibody Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Procalcitonin Antibody Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Medical research institutions
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Procalcitonin Antibody Market Size and Volume Forecast by Type
9.7.1. Polyclonal Procalcitonin Antibody
9.7.2. Monoclonal Procalcitonin Antibody
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Procalcitonin Antibody Demand Share Forecast, 2019-2026
10. Latin America Procalcitonin Antibody Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Procalcitonin Antibody Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Procalcitonin Antibody Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Medical research institutions
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Procalcitonin Antibody Market Size and Volume Forecast by Type
10.7.1. Polyclonal Procalcitonin Antibody
10.7.2. Monoclonal Procalcitonin Antibody
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Procalcitonin Antibody Demand Share Forecast, 2019-2026
11. Europe Procalcitonin Antibody Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Procalcitonin Antibody Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Procalcitonin Antibody Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Medical research institutions
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Procalcitonin Antibody Market Size and Volume Forecast by Type
11.7.1. Polyclonal Procalcitonin Antibody
11.7.2. Monoclonal Procalcitonin Antibody
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Procalcitonin Antibody Demand Share, 2019-2026
12. Asia Pacific Procalcitonin Antibody Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Procalcitonin Antibody Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Procalcitonin Antibody Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Medical research institutions
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Procalcitonin Antibody Market Size and Volume Forecast by Type
12.7.1. Polyclonal Procalcitonin Antibody
12.7.2. Monoclonal Procalcitonin Antibody
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Procalcitonin Antibody Demand Share, 2019-2026
13. Middle East & Africa Procalcitonin Antibody Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Procalcitonin Antibody Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Procalcitonin Antibody Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Medical research institutions
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Procalcitonin Antibody Market Size and Volume Forecast by Type
13.7.1. Polyclonal Procalcitonin Antibody
13.7.2. Monoclonal Procalcitonin Antibody
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Procalcitonin Antibody Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Procalcitonin Antibody Market: Market Share Analysis
14.2. Procalcitonin Antibody Distributors and Customers
14.3. Procalcitonin Antibody Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche Diagnostics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. bioMerieux
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. HyTest
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Wondfo
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ningbo Medicalsystem Biotechnology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Snibe
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Vazyme Biotech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Getein Biotech
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hotgen Biotech
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lumigenex
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Shanghai Medicine'nest Pharmaceutical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Kitgen
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Beijing KeyGen
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Fantibody
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
